T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.82B |
| 2 |
Sea Limited
SE
|
+$1.38B |
| 3 |
Cisco
CSCO
|
+$1.16B |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.54B |
| 2 |
Amazon
AMZN
|
+$1.75B |
| 3 |
Amphenol
APH
|
+$1.65B |
| 4 |
KLA
KLAC
|
+$1.5B |
| 5 |
Xcel Energy
XEL
|
+$1.38B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Pathward Financial
CASH
$1.87B
| $2.22M | ﹤0.01% |
24,885
+3,533
| +17% | +$308K |
|
1777
Global Net Lease
GNL
$1.86B
| $2.22M | ﹤0.01% |
237,114
+41,738
| +21% | +$393K |
|
1778
Dave Inc
DAVE
$5.17B
| $2.21M | ﹤0.01% |
12,702
+1,748
| +16% | +$339K |
|
1779
Diamondrock Hospitality Co
DRH
$2.67B
| $2.21M | ﹤0.01% |
236,067
+38,535
| +20% | +$367K |
|
1780
BioCryst Pharmaceuticals
BCRX
$2.48B
| $2.2M | ﹤0.01% |
230,996
+53,604
| +30% | +$416K |
|
1781
TriCo Bancshares
TCBK
$1.85B
| $2.2M | ﹤0.01% |
46,264
+9,452
| +26% | +$462K |
|
1782
Innoviva
INVA
$1.61B
| $2.19M | ﹤0.01% |
93,940
+16,761
| +22% | +$361K |
|
1783
Edgewise Therapeutics
EWTX
$4.34B
| $2.19M | ﹤0.01% |
69,427
+12,112
| +21% | +$349K |
|
1784
Ziff Davis
ZD
$1.95B
| $2.18M | ﹤0.01% |
51,977
+7,087
| +16% | +$261K |
|
|
CALY
1785
Callaway Golf Company
CALY
$3.28B
| $2.18M | ﹤0.01% |
156,775
+27,043
| +21% | +$379K |
|
1786
T. Rowe Price Floating Rate ETF
TFLR
$670M
| – | – |
0
| – | – |
|
1787
Lakeland Financial Corp
LKFN
$1.58B
| $2.14M | ﹤0.01% |
37,350
+4,765
| +15% | +$279K |
|
1788
Stewart Information Services
STC
$2.11B
| $2.13M | ﹤0.01% |
34,667
+7,289
| +27% | +$486K |
|
1789
Atlanta Braves Holdings Series B
BATRK
$3.27B
| $2.12M | ﹤0.01% |
49,714
+6,651
| +15% | +$276K |
|
1790
Marriott Vacations Worldwide
VAC
$3.52B
| $2.12M | ﹤0.01% |
32,511
+4,298
| +15% | +$266K |
|
1791
Pediatrix Medical
MD
$2.21B
| $2.12M | ﹤0.01% |
98,873
+12,301
| +14% | +$256K |
|
1792
Goodyear
GT
$2.12B
| $2.11M | ﹤0.01% |
317,600
+50,691
| +19% | +$427K |
|
1793
CorVel
CRVL
$3.14B
| $2.1M | ﹤0.01% |
38,510
-185,491
| -83% | -$10.7M |
|
1794
Harley-Davidson
HOG
$2.66B
| $2.1M | ﹤0.01% |
103,911
+10,176
| +11% | +$199K |
|
|
MPT
1795
Medical Properties Trust
MPT
$2.89B
| $2.09M | ﹤0.01% |
451,891
+34,986
| +8% | +$182K |
|
1796
Hilltop Holdings
HTH
$2.28B
| $2.09M | ﹤0.01% |
58,227
+11,042
| +23% | +$405K |
|
1797
PENN Entertainment
PENN
$2.82B
| $2.08M | ﹤0.01% |
138,619
+10,323
| +8% | +$144K |
|
1798
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $2.08M | ﹤0.01% |
30,831
+5,915
| +24% | +$410K |
|
1799
Rush Street Interactive
RSI
$3.16B
| $2.08M | ﹤0.01% |
95,664
-87,470
| -48% | -$1.68M |
|
1800
Omnicell
OMCL
$1.96B
| $2.07M | ﹤0.01% |
62,095
+8,524
| +16% | +$357K |
|
Similar funds
T. Rowe Price Associates's Q1 2026 Portfolio in Review
As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
- T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
- T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
- T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
- T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.